LT - Modifikuoti nukleozidai, nukleotidai, nukleorūgštys bei jų panaudojimas
EN - MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07H 19/10 |
(2006.01) |
|
|
C07H 21/02 |
(2006.01) |
|
|
C12N 15/11 |
(2006.01) |
|
|
A61K 31/7115 |
(2006.01) |
European patent
| (11) |
Number of the document |
4108671 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
22173763.8 |
|
Date of filing the European patent application |
2011-10-03 |
| (97) |
Date of publication of the European application |
2022-12-28 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-11-20
|
| (46) |
Date of publication of the claims translation |
2025-01-10
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
40441310 P |
2010-10-01
|
US |
Inventors
| (72) |
Schrum, Jason P , US
Siddiqi, Suhaib , US
Ejebe, Kenechi , US
|
Grantee
| (73) |
ModernaTX, Inc. ,
325 Binney Street, Cambridge, MA 02142,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Modifikuoti nukleozidai, nukleotidai, nukleorūgštys bei jų panaudojimas |
| |
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-09-26 |
15 |
289.00
EUR
|
Next renewal fee
|
2026-10-03 |
